AN Obstructive Sleep Apnoea (OSA) diagnosis is crucial to sleep health, according to new research released by Philips.
Ahead of World Sleep Day this Fri 13 Mar, the findings show that over half of the population is dissatisfied with their sleep (55%), while more than a third of those (38%) admitting to having done nothing about the issue.
The study also found 80% of sleep apnoea sufferers remain undiagnosed, despite the condition affecting up to 10% of the adult population.
Concerned consumers can take an online test HERE to help understand their risk for OSA.
Philips Australia MD for Australia and NZ warned that if left untreated, sleep apnoea can have serious short and long-term health risks including heart disease, type 2 diabetes, stroke and high blood pressure.
Sufferers are urged to speak to their health professional about getting a diagnosis and treatment.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Mar 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Mar 20
